Fingerprint Dive into the research topics of 'Exposure-response analyses of ramucirumab from two randomized, phase III trials of second-line treatment for advanced gastric or gastroesophageal junction cancer'. Together they form a unique fingerprint.
- Sort by
- Weight
- Alphabetically